Rutgers Launches Lyme Disease Vaccine Study
April 15, 2023
April 15, 2023
NEW BRUNSWICK, New Jersey, April 15 (TNSres) -- Rutgers University issued the following news:
* * *
The university is participating in the effort to determine the efficacy of what could be the first vaccine to prevent Lyme disease in children ages 5 to 17
* * *
Rutgers has been selected as a clinical trial site for the national research study by drug company Pfizer Inc. and French vaccine maker Valneva SE to evaluate the safety and efficacy of . . .
* * *
The university is participating in the effort to determine the efficacy of what could be the first vaccine to prevent Lyme disease in children ages 5 to 17
* * *
Rutgers has been selected as a clinical trial site for the national research study by drug company Pfizer Inc. and French vaccine maker Valneva SE to evaluate the safety and efficacy of . . .